FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
News|Slideshows|November 12, 2019
5 Questions on US Trends in STDs
Author(s)Veronica Hackethal, MD
Combined cases of 3 sexually transmitted diseases reached an all-time high in the US in 2018. Which 3? It's a test of your STD IQ.
Advertisement
Combined cases of syphilis, gonorrhea, and chlamydia reached an all-time high in the United States in 2018. Test your STD IQ with 5 more questions drawn from the latest CDC report.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
FDA acceptance starts review of clesrovimab for second-season RSV prevention in high-risk children younger than 2 years.
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
3
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
4
The Shift From Off-Label Use to On-Label Agitation Therapy
5